Phillip B. Donenberg

2016 - Diffusion Pharmaceuticals

In 2016, Phillip B. Donenberg earned a total compensation of $1.2M as Former Chief Financial Officer at Diffusion Pharmaceuticals, a 251% increase compared to previous year.

Compensation breakdown

Salary$7,343
Other$1,192,883
Total$1,200,226

Donenberg received $1.2M in other compensation, accounting for 99% of the total pay in 2016.

Donenberg also received $7.3K in salary.

Rankings

In 2016, Phillip B. Donenberg's compensation ranked 7,370th out of 14,075 executives tracked by ExecPay. In other words, Donenberg earned more than 47.6% of executives.

ClassificationRankingPercentile
All
7,370
out of 14,075
48th
Division
Manufacturing
2,785
out of 5,486
49th
Major group
Chemicals And Allied Products
915
out of 1,900
52nd
Industry group
Drugs
712
out of 1,543
54th
Industry
Pharmaceutical Preparations
567
out of 1,173
52nd
Source: SEC filing on May 12, 2017.

Donenberg's colleagues

We found five more compensation records of executives who worked with Phillip B. Donenberg at Diffusion Pharmaceuticals in 2016.

2016

Stephen Simes

Diffusion Pharmaceuticals

Chief Executive Officer

2016

David Kalergis

Diffusion Pharmaceuticals

Chief Executive Officer

2016

Mark Weinberg

Diffusion Pharmaceuticals

Former Senior Vice President, Clinical Development

2016

John Gainer

Diffusion Pharmaceuticals

Chief Scientific Officer

2016

Ben Shealy

Diffusion Pharmaceuticals

Secretary

News

You may also like